Our equity-based incentive awards which are mainly comprised of stock options and restricted stock units are designed to align our interests with those of our employees and consultants, including our named executive officers. Our Compensation Committee has responsibility for granting equity-based incentive awards to our named executive officers. Our Compensation Committee has not established policies and practices regarding timing of equity awards in relation to the release of material nonpublic information and does not time the public release of such information based on equity award grant dates nor for the purpose of affecting the value of executive compensation. Our compensation committee does not consider material nonpublic information in setting terms of equity awards, such as grant size or vesting conditions. Vesting of equity awards is generally tied to continuous service with us and serves as an additional retention measure. Our executives generally are awarded an initial new hire grant upon commencement of employment. Additional grants may occur periodically in order to specifically incentivize executives with respect to achieving certain corporate goals or to reward executives for exceptional performance.

The following table presents information required by Item 402(x)(2) of Regulation S-K regarding stock options issued to our named executive officers in fiscal year 2025 during the period beginning four business days before and ending one business day after the filing of a Current Report on Form 8-K that disclosed material non-public information:


										Percentage change in the closing market
										price of the securities underlying the
										award between the trading day ending
				Number of						immediately prior to the disclosure of
				Securities		Option		Grant date fair		material nonpublic information and the
		Option		Underlying		Exercise		value of the		trading day beginning immediately
		Grant		the Options		Price		Options		following the disclosure of material
Name		Date		(#)		($/Sh)		($)		non public information
Dane C. Andreeff		7/2/2025		52,400		9.76		458,814		(5.7%)
Jeffrey S. Mathiesen		7/2/2025		26,200		9.76		229,407		(5.7%)

Award Timing MNPI Considered

false

MNPI Disclosure Timed for Compensation Value

false

Name

Dane C. Andreeff

Exercise Price | $ / shares

$ 9.76

Underlying Security Market Price Change

(5.7)

Awards Close in Time to MNPI Disclosures

Underlying Securities | Options

26,200

Fair Value as of Grant Date | $

$ 229,407